title: Determination of light-chain myosin in pregnancy and under tocolysis.
abstract: Cardiac toxicity of tocolysis containing hexoprenaline (0.3 microgram/min) and the beta 1-blocking agent metoprolol (0.01 mg/min) was investigated using a recently developed monoclonal antibody arised against light-chain myosin in 15 patients and compared with the results in 51 control subjects. There was an increase in the median and 80th percentile values 2, 6, 12 and 24 hours after the beginning of tocolysis but no statistically significant difference between these values and the normal ones could be shown.
authors.affiliation: Department of Obstetrics and Gynecology, University of Innsbruck, Austria.
authors.forename: W
authors.initials: W
authors.lastname: Lechner
authors.forename: E
authors.initials: E
authors.lastname: Artner-Dworzak
authors.forename: K
authors.initials: K
authors.lastname: Heim
authors.forename: C
authors.initials: C
authors.lastname: Marth
authors.forename: B
authors.initials: B
authors.lastname: Puschendorf
mesh_terms: D003327:Coronary Disease / Q000175:diagnosis*; D005260:Female; D006594:Hexoprenaline / Q000009:adverse effects; D006801:Humans; D007124:Immunoenzyme Techniques; D008790:Metoprolol / Q000009:adverse effects; D009218:Myosins / Q000097:blood*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis*; D015145:Tocolysis / Q000009:adverse effects*
chemical_list: D009218:Myosins; D006594:Hexoprenaline; D008790:Metoprolol